These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3547084)

  • 21. Immunologically distinct p53 molecules generated by alternative splicing.
    Arai N; Nomura D; Yokota K; Wolf D; Brill E; Shohat O; Rotter V
    Mol Cell Biol; 1986 Sep; 6(9):3232-9. PubMed ID: 3023970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.
    Wolf D; Harris N; Rotter V
    Cell; 1984 Aug; 38(1):119-26. PubMed ID: 6088057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Characteristics of genome sequences in mouse spleen cells activated in virus-induced Rauscher leukemia].
    Smirnova IA; Domninskiĭ DA; Tatosian AG; Grineva NI; Butenko ZA
    Eksp Onkol; 1987; 9(1):18-22. PubMed ID: 3028755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lack of expression of the protein p53 gene in a human T-cell leukemia line].
    Soudon J; Vilarem MJ; Caron de Fromentel C; Gras MP; Larsen CJ
    C R Acad Sci III; 1988; 306(2):35-8. PubMed ID: 3126985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning and expression analysis of full length mouse cDNA sequences encoding the transformation associated protein p53.
    Jenkins JR; Rudge K; Redmond S; Wade-Evans A
    Nucleic Acids Res; 1984 Jul; 12(14):5609-26. PubMed ID: 6379601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.
    Hinds P; Finlay C; Levine AJ
    J Virol; 1989 Feb; 63(2):739-46. PubMed ID: 2642977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of a c-myc transcript initiated in intron 1 in Friend erythroleukemia cells and in other murine cell types with no evidence of c-myc gene rearrangement.
    Ray D; Meneceur P; Tavitian A; Robert-Lezenes J
    Mol Cell Biol; 1987 Feb; 7(2):940-5. PubMed ID: 3547087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
    Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
    Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relationship between expression of c-myc and P53 genes and terminal differentiation during induced differentiation in Friend erythroleukemia cells].
    Liu HT; Zhang HQ; Xue SB; Du CY; You JS; Song PG; Wang XL; Chen RX
    Shi Yan Sheng Wu Xue Bao; 1988 Sep; 21(3):311-9. PubMed ID: 3066081
    [No Abstract]   [Full Text] [Related]  

  • 30. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.
    Menon AG; Anderson KM; Riccardi VM; Chung RY; Whaley JM; Yandell DW; Farmer GE; Freiman RN; Lee JK; Li FP
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5435-9. PubMed ID: 2142531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction in p53 synthesis during differentiation of Friend-erythroleukemia cells. Correlation with the commitment to terminal cell division.
    Ben-Dori R; Resnitzki D; Kimchi A
    FEBS Lett; 1983 Oct; 162(2):384-9. PubMed ID: 6354748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abelson murine leukemia virus-transformed cells that lack p53 protein synthesis express aberrant p53 mRNA species.
    Wolf D; Admon S; Oren M; Rotter V
    Mol Cell Biol; 1984 Mar; 4(3):552-8. PubMed ID: 6144042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias.
    Howard J; Ung Y; Adachi D; Ben-David Y
    Cell Growth Differ; 1996 Dec; 7(12):1651-60. PubMed ID: 8959333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.
    Wolf D; Rotter V
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):790-4. PubMed ID: 2858093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene.
    Lavigueur A; Maltby V; Mock D; Rossant J; Pawson T; Bernstein A
    Mol Cell Biol; 1989 Sep; 9(9):3982-91. PubMed ID: 2476668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation of genes highly expressed in early and late stages of Friend virus-induced erythroleukemia in mice.
    Misawa Y; Tojo A; Shibuya M
    Biochem Biophys Res Commun; 1990 Jul; 170(1):39-45. PubMed ID: 2115334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 transgenic mice: accelerated erythroleukemia induction by Friend virus.
    Lavigueur A; Bernstein A
    Oncogene; 1991 Dec; 6(12):2197-201. PubMed ID: 1766668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the gene coding for the murine cellular tumour antigen p53.
    Bienz B; Zakut-Houri R; Givol D; Oren M
    EMBO J; 1984 Sep; 3(9):2179-83. PubMed ID: 6092064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induced differentiation of murine erythroleukemia cells: cellular and molecular mechanisms.
    Rifkind RA; Sheffery M; Marks PA
    Adv Cancer Res; 1984; 42():149-66. PubMed ID: 6395654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of a neuropathogenic and nonerythroleukemogenic variant of Friend murine leukemia virus PVC-211.
    Masuda M; Remington MP; Hoffman PM; Ruscetti SK
    J Virol; 1992 May; 66(5):2798-806. PubMed ID: 1560524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.